FI850829L - Foerlaekemedel foer allopurinol. - Google Patents

Foerlaekemedel foer allopurinol.

Info

Publication number
FI850829L
FI850829L FI850829A FI850829A FI850829L FI 850829 L FI850829 L FI 850829L FI 850829 A FI850829 A FI 850829A FI 850829 A FI850829 A FI 850829A FI 850829 L FI850829 L FI 850829L
Authority
FI
Finland
Prior art keywords
group
formula
nitrogen
same meaning
cr6r7
Prior art date
Application number
FI850829A
Other languages
English (en)
Other versions
FI83221B (fi
FI83221C (fi
FI850829A0 (fi
Inventor
Hans Bundgaard
Erik Falch
Original Assignee
Gea As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea As filed Critical Gea As
Publication of FI850829L publication Critical patent/FI850829L/fi
Publication of FI850829A0 publication Critical patent/FI850829A0/fi
Publication of FI83221B publication Critical patent/FI83221B/fi
Application granted granted Critical
Publication of FI83221C publication Critical patent/FI83221C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI850829A 1983-06-30 1985-02-28 Foerfarande foer framstaellning av som laekemedel anvaendbara 1-, 1,5- eller 2,5-substituerade 1,5- eller 2,5 -dihydro-4h-pyrazol-/3,4-d/-pyrimidin-4-oner. FI83221C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK302883 1983-06-30
DK3028/83A DK302883D0 (da) 1983-06-30 1983-06-30 Allopurinol prodrugs
PCT/DK1984/000057 WO1985000368A1 (en) 1983-06-30 1984-06-19 Allopurinol prodrugs
DK8400057 1984-06-19

Publications (4)

Publication Number Publication Date
FI850829L true FI850829L (fi) 1985-02-28
FI850829A0 FI850829A0 (fi) 1985-02-28
FI83221B FI83221B (fi) 1991-02-28
FI83221C FI83221C (fi) 1991-06-10

Family

ID=8118314

Family Applications (1)

Application Number Title Priority Date Filing Date
FI850829A FI83221C (fi) 1983-06-30 1985-02-28 Foerfarande foer framstaellning av som laekemedel anvaendbara 1-, 1,5- eller 2,5-substituerade 1,5- eller 2,5 -dihydro-4h-pyrazol-/3,4-d/-pyrimidin-4-oner.

Country Status (10)

Country Link
US (1) US4694006A (fi)
EP (1) EP0148883B1 (fi)
JP (1) JPS60501708A (fi)
DE (1) DE3481369D1 (fi)
DK (1) DK302883D0 (fi)
ES (1) ES8600293A1 (fi)
FI (1) FI83221C (fi)
IE (1) IE57696B1 (fi)
IT (1) IT1214854B (fi)
WO (1) WO1985000368A1 (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943579A (en) * 1987-10-06 1990-07-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble prodrugs of camptothecin
IT1244501B (it) * 1991-03-22 1994-07-15 Sigma Tau Ind Farmaceuti Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono
US6110923A (en) * 1994-06-22 2000-08-29 Biochem Pharma Inc. Method for treating cancer using novel substituted purinyl derivatives with immunomodulating activity
US6908900B2 (en) * 2001-01-17 2005-06-21 Zimmer & Associates Ag Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients
US7671029B2 (en) * 1999-08-06 2010-03-02 Immupharma Sa Compositions and methods for enhanced pharmacological activity of compositions comprising peptide drug substances
WO2003020321A2 (en) * 2001-09-06 2003-03-13 Zimmer Robert H Derivatives of pseudo-peptides, their preparation and their biological uses
US20040152769A1 (en) * 2002-11-09 2004-08-05 Ekwuribe Nnochiri Nkem Modified carbamate-containing prodrugs and methods of synthesizing same
WO2010151711A1 (en) 2009-06-25 2010-12-29 Alkermes, Inc. Prodrugs of nh-acidic compounds
EP2585066B1 (en) * 2010-06-24 2018-09-26 Alkermes Pharma Ireland Limited Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
US9034867B2 (en) 2011-03-18 2015-05-19 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising sorbitan esters
NZ722096A (en) 2011-12-15 2016-11-25 Alkermes Pharma Ireland Ltd Prodrugs of secondary amine compounds
CA2867137C (en) 2012-03-19 2020-12-08 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising aripiprazole prodrugs and benzyl alcohol
JP6471089B2 (ja) 2012-03-19 2019-02-13 アルカームス ファーマ アイルランド リミテッド 脂肪酸エステルを含む医薬組成物
JP6219918B2 (ja) 2012-03-19 2017-10-25 アルカームス ファーマ アイルランド リミテッド グリセロールエステルを含む医薬組成物
ES2792149T3 (es) 2012-09-19 2020-11-10 Alkermes Pharma Ireland Ltd Composiciones farmacéuticas que tienen estabilidad de almacenamiento mejorada
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use
MX2016012041A (es) 2014-03-20 2017-01-19 Alkermes Pharma Ireland Ltd Formulaciones de aripiprazol que tienen mayores velocidades de inyeccion.
CN105272984B (zh) * 2014-06-23 2019-06-14 湘北威尔曼制药股份有限公司 吡唑并[3,4-d]嘧啶-4-酮衍生物、其制备方法和应用
WO2016015177A1 (zh) * 2014-06-23 2016-02-04 北京新天宇科技开发有限公司 吡唑并[3,4-d]嘧啶-4-酮衍生物、其制备方法和应用
JP7384812B2 (ja) 2018-03-05 2023-11-21 アルカームス ファーマ アイルランド リミテッド アリピプラゾール投与戦略

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2868803A (en) * 1956-02-10 1959-01-13 Ciba Pharm Prod Inc New pyrazoles and method of preparing same
US3474098A (en) * 1968-08-22 1969-10-21 Burroughs Wellcome Co Pyrazolo-(3,4-d) pyrimidines
GB1339748A (en) * 1970-07-02 1973-12-05 Ici Ltd Pyrimidine derivatives
DK172081A (da) * 1980-04-21 1981-10-22 Merck & Co Inc Mercaptoforbindelse og fremgangsmaade til fremstilling deraf
DE3131365A1 (de) * 1981-08-07 1983-02-24 Henkel KGaA, 4000 Düsseldorf Neue diglycidyl-substituierte heterocyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung in arzneimittelzubereitungen mit cytostatischer wirksamkeit
US4565868A (en) * 1983-02-07 1986-01-21 Syntex (U.S.A.) Inc. Process for preparing guanine derivatives
US4555579A (en) * 1983-03-24 1985-11-26 E. R. Squibb & Sons, Inc. Dioxolenylmethyl ester prodrugs of phosphinic acid ace inhibitors

Also Published As

Publication number Publication date
WO1985000368A1 (en) 1985-01-31
IT1214854B (it) 1990-01-18
IE57696B1 (en) 1993-03-10
DE3481369D1 (en) 1990-03-22
JPS60501708A (ja) 1985-10-11
ES533873A0 (es) 1985-10-01
FI83221B (fi) 1991-02-28
FI83221C (fi) 1991-06-10
US4694006A (en) 1987-09-15
EP0148883A1 (en) 1985-07-24
EP0148883B1 (en) 1990-02-14
DK302883D0 (da) 1983-06-30
IE841659L (en) 1984-12-30
ES8600293A1 (es) 1985-10-01
FI850829A0 (fi) 1985-02-28
IT8467669A0 (it) 1984-06-29

Similar Documents

Publication Publication Date Title
FI850829L (fi) Foerlaekemedel foer allopurinol.
DE69428903D1 (de) Substituierte 2-aminotetraline
ES527954A1 (es) Un procedimiento para preparar isoxazoles
SE8704599D0 (sv) Teobrominderivat
IL69912A0 (en) Substituted 1-hydroxyethyl-triazolyl derivatives,their preparation and their use as plant protection agents
DK149857C (da) Analogifremgangsmaade til fremstilling af 9-(2-hydroxyalkyl)-purinsalte
SE8104783L (sv) Heterocykliska foreningar
ES440426A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina.
ES8107001A1 (es) Un metodo de preparar nuevas diaminas
FI832639A0 (fi) Nya muramylpeptider och foerfarande foer deras framstaellning
ES8706634A1 (es) Procedimiento para la obtencion de compuestos de amida
ES2001503A6 (es) Un procedimiento para producir un copoliester susceptible de tratamiento en masa fundida
ES476167A1 (es) Procedimiento para la preparacion de nuevas imidazo-isoquinolein-dionas.
EP0465156A3 (en) A hydraulic, lubricating and coupling composition
ES449765A1 (es) Procedimiento para la preparacion de nuevas homoftalimidas.
SE7704246L (sv) Desinfektionsmedel
FI823458A0 (fi) Substituerade tiazolidinylestrar av mineralsyror
ES8202003A1 (es) Un procedimiento para la preparacion de derivados de ergoli-na
ES8305758A1 (es) "un procedimiento para la preparacion de 2-(1,4-benzodioxan-2-il-metil)-imidazolina".
SE321467B (fi)
DK89685A (da) Allopurinolderivater
ES8705426A1 (es) Un procedimiento para la preparacion de un derivado de piperazina.
ES8504772A1 (es) Un procedimiento para preparar un compuesto de 7-(4-piridil)-1,8-naftiridina.
Smith et al. Trans-4, 5, 13, 14-tetradehydro-PGI 1 amides
ES8302712A1 (es) Un nuevo procedimiento de preparacion de imidazobenzodiazepinas.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: A/S GEA FARMACEUTISK FABRIK